Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pulmonx Corp
LUNGCurrent price
6.45 USD
-0.28 USD (-4.16%)
Last closed
6.72 USD
Company
pulmonx.com
ISIN
US7458481014
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
293 789 984 USD
Yield for 12 month
-40.33 %
1Y
3Y
5Y
10Y
15Y
LUNG
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Address: 700 Chesapeake Drive, Redwood City, CA, United States, 94063
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.5 USDP/E ratio
–Dividend Yield
–Current Year
+68 675 000 USD
Last Year
+53 662 000 USD
Current Quarter
+20 387 000 USD
Last Quarter
+20 783 000 USD
Current Year
+50 352 000 USD
Last Year
+39 865 000 USD
Current Quarter
+15 026 000 USD
Last Quarter
+15 307 000 USD
Key Figures LUNG
1 year
3 years
5 years
10 years
EBITDA
-55 003 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.04 %
PEG Ratio
–
Return On Equity TTM
-51.99 %
Wall Street Target Price
13.5 USD
Revenue TTM
79 302 000 USD
Book Value
2.38 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
15.4 %
Dividend Yield
–
Gross Profit TTM
39 865 000 USD
Earnings per share
-1.47 USD
Diluted Eps TTM
-1.47 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-72.01 %
Dividend Analytics LUNG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LUNG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation LUNG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
28.3286
Enterprise Value Revenue
3.0494
Price Sales TTM
3.7047
Enterprise Value EBITDA
-5.617
Price Book MRQ
3.1279
Financials LUNG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LUNG
For 52 weeks
5.46 USD
14.84 USD
50 Day MA
7.23 USD
Shares Short Prior Month
1 675 074
200 Day MA
8.21 USD
Short Ratio
8.38
Shares Short
1 781 174
Short Percent
6.39 %
BeatStart